Arm 1: Molecularly Tailored Therapy: Clinical Trials

1 trial of Arm 1: Molecularly Tailored Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1

Follow Arm 1: Molecularly Tailored Therapy: new trials by email Literature Review of Arm 1: Molecularly Tailored Therapy trials Research Report on Arm 1: Molecularly Tailored Therapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Molecularly Tailored Therapy in Advanced Pancreatic Cancer
Arm 1: Molecularly Tailored Therapy, Arms 2: Standard-of-Care Therapy, Arm 3: Standard-of-Care Observational Cohort - Pancreatic Cancer
Phase 2Not yet recruitingHerlev Hospital12002026-10-012026-09-03

Conditions studied

Pancreatic Neoplasms (1)

Sponsors

Herlev Hospital (1)

Countries

Denmark (1)

Top investigators

Inna Markovna Chen, MD (1)